OUR CURIOUS AMALGAM

#96 Can They Really Say That? Product Denigration Under French Antitrust Law

At its most basic, marketing often consists of simply explaining a product's qualities relative to its alternatives. Can this go too far and amount to a competition law infringement? Isabelle de Silva, President of the French Competition Authority (FCA), and Bill Batchelor join John Roberti and Matthew Hall to discuss product denigration by reference to the FCA's cases in the pharma sector. Listen to this episode to learn more about these cases and how to draw the line between illegal disparagement of rivals and factual communication of differences.

Guest(s):

Isabelle de Silva, President, French Competition Authority

Bill Batchelor, Partner, Skadden, Arps, Slate, Meagher & Flom LLP

Related Links:

FCA's AMD (Avastin) decision September 2020
https://www.autoritedelaconcurrence.fr/en/article/treatment-amd-autorite-fines-3-laboratories-abusive-practices

FCA's Subutex decision December 2013
https://www.autoritedelaconcurrence.fr/en/press-release/autorite-de-la-concurrence-fines-schering-plough-pharmaceutical-laboratory-total-153

FCA's Plavix decision May 2013
https://www.autoritedelaconcurrence.fr/en/press-release/autorite-de-la-concurrence-fines-sanofi-aventis-total-eu406-million-disparaging

FCA's Durogesic decision December 2017
https://www.autoritedelaconcurrence.fr/en/communiques-de-presse/20-december-2017-medicinal-products

Hosted by:

John Roberti and Matthew Hall

Link to Our Curious Amalgam’s website episode page:
https://podcast.ourcuriousamalgam.com/episode/96-can-they-really-say-that-product-denigration-under-french-antitrust-law/